| Dec 2, 2015 | Pfizer, Inc. | OTH | $5,700,000 |
| Dec 2, 2015 | Pfizer, Inc. | OTH | $5,700,000 |
| Nov 3, 2015 | Amgen Inc. | OTH | $4,150,000 |
| Nov 24, 2015 | AstraZeneca Pharmaceuticals LP | OTH | $4,150,000 |
| Nov 3, 2015 | Amgen Inc. | OTH | $4,150,000 |
| Nov 3, 2015 | AbbVie Inc. | OTH | $4,150,000 |
| Jan 29, 2016 | sanofi-aventis U.S. LLC | OTH | $4,150,000 |
| Nov 24, 2015 | AstraZeneca Pharmaceuticals LP | OTH | $4,150,000 |
| Jan 29, 2016 | sanofi-aventis U.S. LLC | OTH | $4,150,000 |
| Nov 3, 2015 | AbbVie Inc. | OTH | $4,150,000 |
| Nov 24, 2015 | Novartis Pharmaceuticals Corporation | OTH | $2,880,000 |
| Nov 24, 2015 | Novartis Pharmaceuticals Corporation | OTH | $2,880,000 |
| Jan 29, 2016 | Novo Nordisk Inc. | OTH | $2,800,000 |
| Mar 14, 2016 | GlaxoSmithKline | OTH | $2,800,000 |
| Jan 29, 2016 | Novo Nordisk Inc. | OTH | $2,800,000 |
| Feb 18, 2016 | Allergan USA, Inc. | OTH | $2,800,000 |
| Mar 14, 2016 | GlaxoSmithKline | OTH | $2,800,000 |
| Nov 3, 2015 | Eli Lilly and Company | OTH | $2,800,000 |
| Nov 3, 2015 | Eli Lilly and Company | OTH | $2,800,000 |
| Feb 18, 2016 | Allergan USA, Inc. | OTH | $2,800,000 |
| Mar 7, 2016 | Astellas Pharma US, Inc. | OTH | $1,075,000 |
| Nov 24, 2015 | Otsuka America, Inc. (OAI) | OTH | $1,075,000 |
| Nov 3, 2015 | Boehringer Ingelheim Pharmaceuticals, Inc. | OTH | $1,075,000 |
| Nov 3, 2015 | Boehringer Ingelheim Pharmaceuticals, Inc. | OTH | $1,075,000 |
| Nov 24, 2015 | Otsuka America, Inc. (OAI) | OTH | $1,075,000 |
| Mar 7, 2016 | Astellas Pharma US, Inc. | OTH | $1,075,000 |
| Dec 22, 2015 | Genentech, Inc. | OTH | $1,000,000 |
| Dec 22, 2015 | Genentech, Inc. | OTH | $1,000,000 |
| Nov 24, 2015 | EMD Serono, Inc. | OTH | $385,000 |
| Nov 24, 2015 | Mallinckrodt Pharmaceuticals | OTH | $385,000 |
| Nov 24, 2015 | EMD Serono, Inc. | OTH | $385,000 |
| Nov 24, 2015 | Mallinckrodt Pharmaceuticals | OTH | $385,000 |
| Jan 29, 2016 | Daiichi Sankyo, Inc. | OTH | $179,732 |
| Jan 29, 2016 | Daiichi Sankyo, Inc. | OTH | $179,732 |
| Dec 22, 2015 | Pharmaceutical Research and Manufacturers of America | OTH | $137,679.45 |
| Dec 22, 2015 | Pharmaceutical Research and Manufacturers of America | OTH | $137,679.45 |
| Oct 13, 2015 | AstraZeneca Pharmaceuticals LP | OTH | $115,000 |
| Nov 24, 2015 | sanofi-aventis U.S. LLC | OTH | $115,000 |
| Oct 13, 2015 | AstraZeneca Pharmaceuticals LP | OTH | $115,000 |
| Nov 24, 2015 | sanofi-aventis U.S. LLC | OTH | $115,000 |
| Nov 3, 2015 | Amgen Inc. | OTH | $115,000 |
| Nov 3, 2015 | Amgen Inc. | OTH | $115,000 |
| Nov 3, 2015 | AbbVie Inc. | OTH | $115,000 |
| Nov 3, 2015 | AbbVie Inc. | OTH | $115,000 |
| Nov 24, 2015 | Novo Nordisk Inc. | OTH | $80,000 |
| Jan 29, 2016 | GlaxoSmithKline | OTH | $80,000 |
| Jan 29, 2016 | GlaxoSmithKline | OTH | $80,000 |
| Nov 3, 2015 | Biogen | OTH | $80,000 |
| Nov 3, 2015 | Eli Lilly and Company | OTH | $80,000 |
| Nov 24, 2015 | Allergan USA, Inc. | OTH | $80,000 |
| Nov 24, 2015 | Novo Nordisk Inc. | OTH | $80,000 |
| Nov 3, 2015 | Biogen | OTH | $80,000 |
| Nov 3, 2015 | Eli Lilly and Company | OTH | $80,000 |
| Nov 24, 2015 | Allergan USA, Inc. | OTH | $80,000 |
| Oct 13, 2015 | Alkermes | OTH | $52,000 |
| Oct 13, 2015 | Alkermes | OTH | $52,000 |
| Oct 8, 2015 | Bayer Corporation | OTH | $30,000 |
| Nov 3, 2015 | Otsuka America, Inc. (OAI) | OTH | $30,000 |
| Nov 24, 2015 | Celgene Corporation | OTH | $30,000 |
| Nov 3, 2015 | Astellas Pharma US, Inc. | OTH | $30,000 |
| Oct 8, 2015 | Bayer Corporation | OTH | $30,000 |
| Nov 24, 2015 | Celgene Corporation | OTH | $30,000 |
| Nov 3, 2015 | Otsuka America, Inc. (OAI) | OTH | $30,000 |
| Nov 3, 2015 | Boehringer Ingelheim Pharmaceuticals, Inc. | OTH | $30,000 |
| Nov 3, 2015 | Astellas Pharma US, Inc. | OTH | $30,000 |
| Nov 24, 2015 | Takeda Pharmaceuticals U.S.A., Inc. | OTH | $30,000 |
| Nov 3, 2015 | Boehringer Ingelheim Pharmaceuticals, Inc. | OTH | $30,000 |
| Nov 24, 2015 | Takeda Pharmaceuticals U.S.A., Inc. | OTH | $30,000 |
| Jan 31, 2016 | Pharmaceutical Research and Manufacturers of America | OTH | $28,104.61 |
| Jan 31, 2016 | Pharmaceutical Research and Manufacturers of America | OTH | $28,104.61 |
| Mar 31, 2016 | Pharmaceutical Research and Manufacturers of America | OTH | $20,163.99 |
| Mar 31, 2016 | Pharmaceutical Research and Manufacturers of America | OTH | $20,163.99 |
| Feb 29, 2016 | Pharmaceutical Research and Manufacturers of America | OTH | $15,965.04 |
| Feb 29, 2016 | Pharmaceutical Research and Manufacturers of America | OTH | $15,965.04 |
| Oct 8, 2015 | Lundbeck LLC | OTH | $10,000 |
| Oct 8, 2015 | Lundbeck LLC | OTH | $10,000 |
| Nov 30, 2015 | Pharmaceutical Research and Manufacturers of America | OTH | $8,779.38 |
| Nov 30, 2015 | Pharmaceutical Research and Manufacturers of America | OTH | $8,779.38 |
| Oct 31, 2015 | Pharmaceutical Research and Manufacturers of America | OTH | $6,805.83 |
| Oct 31, 2015 | Pharmaceutical Research and Manufacturers of America | OTH | $6,805.83 |
| Dec 31, 2015 | Pharmaceutical Research and Manufacturers of America | OTH | $4,814.35 |
| Dec 31, 2015 | Pharmaceutical Research and Manufacturers of America | OTH | $4,814.35 |
| Mar 31, 2016 | California Bank & Trust | OTH | $2,890.3 |
| Mar 31, 2016 | California Bank & Trust | OTH | $2,890.3 |
| Feb 29, 2016 | California Bank & Trust | OTH | $2,569.12 |
| Feb 29, 2016 | California Bank & Trust | OTH | $2,569.12 |
| Nov 3, 2015 | Orexigen Therapeutics, Inc. | OTH | $2,000 |
| Nov 3, 2015 | Orexigen Therapeutics, Inc. | OTH | $2,000 |
| Jan 29, 2016 | California Bank & Trust | OTH | $1,897.96 |
| Jan 29, 2016 | California Bank & Trust | OTH | $1,897.96 |
| Dec 31, 2015 | California Bank & Trust | OTH | $1,818.47 |
| Dec 31, 2015 | California Bank & Trust | OTH | $1,818.47 |
| Nov 30, 2015 | California Bank & Trust | OTH | $1,353.36 |
| Nov 30, 2015 | California Bank & Trust | OTH | $1,353.36 |
| Oct 30, 2015 | California Bank & Trust | OTH | $789.32 |
| Oct 30, 2015 | California Bank & Trust | OTH | $789.32 |